Handelsavisen
prelaunch
Companies Healthcare 4197.TWO
41
4197.TWO TPEx Medical Equipment, Supplies & Distribution

4197.Two

$9,70
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
ROE
Net margin
Debt / equity
0,48
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

4197.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Business. 4197.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 4197.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 4197.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    4197.TWO operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    4197.TWO maintains a debt-to-equity ratio of 0.48, indicating a relatively conservative capital structure with equity significantly outweighing debt. The company holds cash and equivalents of TWD 69,334,000, which is partially offset by long-term debt of TWD 95,364,000, resulting in a net cash position that is negative after subtracting total debt. This suggests potential liquidity constraints, particularly if the company needs to service debt obligations without additional financing.

    Profitability metrics for 4197.TWO are not explicitly provided, but the operating cash flow of TWD 13,366,000 indicates the company generates positive cash from operations. However, without access to industry-specific preferred metrics such as EBITDA margins or ROIC, a direct comparison to cohort medians is not possible. The company's capital expenditure of TWD -5,383,000 suggests it is not currently investing heavily in new assets, which may limit long-term growth potential.

    The company's geographic and segment exposure is not detailed in the available data, but the absence of disclosed revenue concentration by region or business line implies a potentially diversified revenue base. This could reduce exposure to regional economic downturns or sector-specific risks.

    The company's growth trajectory is not clearly defined in the available data, as no outlook figures or revenue history are provided. However, the current operating cash flow and relatively low debt levels suggest the company is in a stable financial position, though the lack of capital expenditure may indicate a conservative or maintenance-oriented growth strategy.

    Risk factors for 4197.TWO include medium liquidity risk, as the company's cash reserves are partially offset by long-term debt obligations. The dilution risk is assessed as low, with no significant dilution potential reported. However, the company's net cash position being negative after subtracting total debt raises concerns about its ability to meet long-term obligations without additional financing.

    Recent events or filings are not detailed in the available data, so no specific recent developments can be cited. The company's financial statements and disclosures do not indicate any material changes in operations or strategy in the near term.

    Key takeaways
    • 4197.TWO maintains a conservative capital structure with a debt-to-equity ratio of 0.48.
    • The company's net cash position is negative after subtracting total debt, indicating potential liquidity constraints.
    • Operating cash flow is positive at TWD 13,366,000, but capital expenditure is minimal, suggesting a conservative growth strategy.
    • The company's risk profile is characterized by medium liquidity risk and low dilution risk.
    • No recent events or filings are disclosed that would indicate significant changes in operations or strategy.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $9,70
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    -$26.0M
    Current ratio
    Debt / equity
    0.5
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    -3.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Capex / Rev-3,0 %Above median
    D/E0,48Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    Source documents
    • 4197.TWO Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    4197.TWOCanonical
    TPEx · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage